The table below shows HAEMONETICS CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q4 2025
Q3 2025
Q2 2025
Q4 2024
Q3 2024
Q2 2024
Revenue
$338.97M
$327.31M
$321.39M
$348.54M
$345.51M
$336.17M
Cost of revenue
$136.58M
$132.57M
$129.15M
$155.00M
$158.07M
$161.25M
Gross profit
$202.39M
$194.74M
$192.24M
$193.55M
$187.44M
$174.92M
R&D
$14.19M
$14.87M
$16.26M
$15.83M
$14.14M
$14.45M
HAE annual revenue (10-K history)
HAEMONETICS CORP reported annual revenue of $1.33B for fiscal year 2026. That is down 2.0% from $1.36B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $886.12M (FY 2017) to $1.33B. Figures come from the company's audited annual reports as filed with the SEC.
